These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30257186)

  • 1. No differences were found between effect estimates from conventional and registry-based randomized controlled trials.
    Mathes T; Klaßen P; Pieper D
    J Clin Epidemiol; 2019 Jan; 105():80-91. PubMed ID: 30257186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paper II: thematic framework analysis of registry-based randomized controlled trials provided insights for designing trial ready registries.
    Krause KR; Tay J; Douglas WA; Sammy A; Baba A; Goren K; Thombs BD; Howie AH; Oskoui M; Frøbert O; Trakadis Y; Little J; Potter BK; Butcher NJ; Offringa M
    J Clin Epidemiol; 2023 Jul; 159():330-343. PubMed ID: 37146660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Registry-based randomised controlled trials: conduct, advantages and challenges-a systematic review.
    Shiely F; O Shea N; Murphy E; Eustace J
    Trials; 2024 Jun; 25(1):375. PubMed ID: 38863017
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Registry-based randomized controlled trials merged the strength of randomized controlled trails and observational studies and give rise to more pragmatic trials.
    Mathes T; Buehn S; Prengel P; Pieper D
    J Clin Epidemiol; 2018 Jan; 93():120-127. PubMed ID: 28951111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. "Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians.
    Prang KH; Karanatsios B; Zhang A; Verbunt E; Wong HL; Wong V; Gately L; Tran B; Gibbs P; Kelaher M
    Trials; 2023 Feb; 24(1):92. PubMed ID: 36747274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity subgroup analysis based on single-center vs. multi-center trial status when interpreting meta-analyses pooled estimates: the logical way forward.
    Alexander PE; Bonner AJ; Agarwal A; Li SA; Hariharan A; Izhar Z; Bhatnagar N; Alba C; Akl EA; Fei Y; Guyatt GH; Beyene J
    J Clin Epidemiol; 2016 Jun; 74():80-92. PubMed ID: 26597972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paper I: Heterogeneous use of registry data for participant identification and primary outcome ascertainment is found in registry-based randomized controlled trials: A scoping review.
    Baba A; Tay J; Sammy A; Douglas WA; Goren K; Krause KR; Howie AH; Little J; Oskoui M; Taljaard M; Thombs BD; Potter BK; Butcher NJ; Offringa M
    J Clin Epidemiol; 2023 Jul; 159():289-299. PubMed ID: 37146658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining key design elements of registry-based randomised controlled trials: a scoping review.
    Karanatsios B; Prang KH; Verbunt E; Yeung JM; Kelaher M; Gibbs P
    Trials; 2020 Jun; 21(1):552. PubMed ID: 32571382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Registry randomised trials: a methodological perspective.
    Doherty DA; Tong SYC; Reilly J; Shrapnel J; McDonald S; Ahern S; Harris I; Tam CS; Brennan AL; Hodgson C; Wilcox L; Balagurunathan A; Butcher BE; Reid CM
    BMJ Open; 2023 Mar; 13(3):e068057. PubMed ID: 36858472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of nuisance parameters in pediatric versus adult randomized trials: a meta-epidemiologic empirical evaluation.
    Vandermeer B; van der Tweel I; Jansen-van der Weide MC; Weinreich SS; Contopoulos-Ioannidis DG; Bassler D; Fernandes RM; Askie L; Saloojee H; Baiardi P; Ellenberg SS; van der Lee JH
    BMC Med Res Methodol; 2018 Jan; 18(1):7. PubMed ID: 29321002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical registries data quality attributes to support registry-based randomised controlled trials: A scoping review.
    Prang KH; Karanatsios B; Verbunt E; Wong HL; Yeung J; Kelaher M; Gibbs P
    Contemp Clin Trials; 2022 Aug; 119():106843. PubMed ID: 35792338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stepped wedge cluster randomized controlled trial designs: a review of reporting quality and design features.
    Grayling MJ; Wason JM; Mander AP
    Trials; 2017 Jan; 18(1):33. PubMed ID: 28109321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opportunities and barriers for the use of Australian cancer registries as platforms for randomized clinical trials.
    Yan MK; Adler NR; Heriot N; Shang C; Zalcberg JR; Evans S; Wolfe R; Mar VJ
    Asia Pac J Clin Oncol; 2022 Aug; 18(4):344-352. PubMed ID: 34811922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    BMC Med Res Methodol; 2018 May; 18(1):42. PubMed ID: 29776394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical trial registries are of minimal use for identifying selective outcome and analysis reporting.
    Norris SL; Holmer HK; Fu R; Ogden LA; Viswanathan MS; Abou-Setta AM
    Res Synth Methods; 2014 Sep; 5(3):273-84. PubMed ID: 26052852
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.